(Q38722030)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

review article

1 reference

title

β-adrenergic receptor signalling and its functional consequences in the diseased heart (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author

Jolanda van der Velden

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Diederik W D Kuster

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Aref Najafi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Vasco Sequeira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

19 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Investigation

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

362-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

Cardiac excitation-contraction coupling

7 March 2020

cites work

1 reference

Adrenergic signaling in heart failure: a balance of toxic and protective effects

21 January 2018

1 reference

Modification by beta-adrenergic blockade of the circulatory respones to acute hypoxia in man.

21 January 2018

1 reference

The G protein-coupled receptor repertoires of human and mouse

21 January 2018

1 reference

Seven-transmembrane-spanning receptors and heart function

21 January 2018

1 reference

Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy

21 January 2018

1 reference

Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium

21 January 2018

1 reference

G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization

21 January 2018

1 reference

Beta3-adrenoreceptors in cardiovasular diseases: new roles for an "old" receptor

21 January 2018

1 reference

Myocyte adrenoceptor signaling pathways

21 January 2018

1 reference

Cardiac myosin binding protein C phosphorylation in cardiac disease.

21 January 2018

1 reference

Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes

21 January 2018

1 reference

Phospholamban: a prominent regulator of myocardial contractility

21 January 2018

1 reference

Modulation of excitation-contraction coupling by isoproterenol in cardiomyocytes with controlled SR Ca2+ load and Ca2+ current trigger

21 January 2018

1 reference

Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels.

21 January 2018

1 reference

Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes

21 January 2018

1 reference

A-kinase anchoring protein targeting of protein kinase A in the heart

21 January 2018

1 reference

A-kinase anchoring proteins: molecular regulators of the cardiac stress response

21 January 2018

1 reference

Mechanisms of protein kinase A anchoring

21 January 2018

1 reference

Protein kinase A type I and type II define distinct intracellular signaling compartments.

21 January 2018

1 reference

Intracellular targeting of the type-I alpha regulatory subunit of cAMP-dependent protein kinase

21 January 2018

1 reference

Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I.

21 January 2018

1 reference

Compartmentalization of beta-adrenergic signals in cardiomyocytes

21 January 2018

1 reference

cGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac Myocytes

21 January 2018

1 reference

AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum

21 January 2018

1 reference

Cardiac troponin T, a sarcomeric AKAP, tethers protein kinase A at the myofilaments

21 January 2018

1 reference

Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C

21 January 2018

1 reference

Direct AKAP-mediated protein-protein interactions as potential drug targets

21 January 2018

1 reference

Adenylyl cyclase--A-kinase anchoring protein complexes: the next dimension in cAMP signaling

21 January 2018

1 reference

Neurohumoral activation in heart failure: the role of adrenergic receptors.

21 January 2018

1 reference

What is the role of beta-adrenergic signaling in heart failure?

21 January 2018

1 reference

Plasma norepinephrine in congestive heart failure

21 January 2018

1 reference

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

21 January 2018

1 reference

Beta-adrenergic signaling in heart failure-adapt or die.

21 January 2018

1 reference

Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor

21 January 2018

1 reference

Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice

21 January 2018

1 reference

Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation

21 January 2018

1 reference

Mechanisms of acute desensitization of the beta2AR-adenylyl cyclase pathway in human airway smooth muscle

21 January 2018

1 reference

Beta-agonist- and prostaglandin E1-induced translocation of the beta-adrenergic receptor kinase: evidence that the kinase may act on multiple adenylate cyclase-coupled receptors

21 January 2018

1 reference

G protein coupled receptor kinases as therapeutic targets in cardiovascular disease

21 January 2018

1 reference

GRK mythology: G-protein receptor kinases in cardiovascular disease

21 January 2018

1 reference

Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease

21 January 2018

1 reference

Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function

21 January 2018

1 reference

Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization

21 January 2018

1 reference

Transduction of receptor signals by beta-arrestins

21 January 2018

1 reference

β-Arrestin-mediated receptor trafficking and signal transduction

21 January 2018

1 reference

The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification

21 January 2018

1 reference

Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins

21 January 2018

1 reference

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

21 January 2018

1 reference

Protein kinase A anchoring

21 January 2018

1 reference

Reorganized PKA-AKAP associations in the failing human heart.

21 January 2018

1 reference

Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes

21 January 2018

1 reference

Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor

21 January 2018

1 reference

Metabolic remodelling of the failing heart: beneficial or detrimental?

21 January 2018

1 reference

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

21 January 2018

1 reference

Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

Galpha i2 enhances in vivo activation of and insulin signaling to GLUT4.

21 January 2018

1 reference

Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance.

21 January 2018

1 reference

The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance

21 January 2018

1 reference

Adrenergic receptors and metabolism: role in development of cardiovascular disease

21 January 2018

1 reference

Insulin inhibits cardiac contractility by inducing a Gi-biased β2-adrenergic signaling in hearts.

21 January 2018

1 reference

Molecular and cellular mechanisms of myocardial failure

21 January 2018

1 reference

Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy

21 January 2018

1 reference

Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

21 January 2018

1 reference

Metabolic mechanisms in heart failure

21 January 2018

1 reference

Adrenergic signaling and oxidative stress: a role for sirtuins?

21 January 2018

1 reference

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

21 January 2018

1 reference

21 January 2018

1 reference

Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

21 January 2018

1 reference

Advantages and Disadvantages of Beta- Adrenergic Blocking Drugs in Hypertension

21 January 2018

1 reference

Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.

21 January 2018

1 reference

Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.

21 January 2018

1 reference

A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling

21 January 2018

1 reference

Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

21 January 2018

1 reference

The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist

21 January 2018

1 reference

Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol

21 January 2018

1 reference

Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin.

21 January 2018

1 reference

β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing

21 January 2018

1 reference

Cardiac myosin activation: a potential therapeutic approach for systolic heart failure

21 January 2018

1 reference

The failing heart--an engine out of fuel

21 January 2018

1 reference

Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart

21 January 2018

1 reference

Randomized clinical trials with levosimendan

21 January 2018

1 reference

Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure

21 January 2018

1 reference

Exercise and the cardiovascular system: clinical science and cardiovascular outcomes

21 January 2018

1 reference

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

21 January 2018

1 reference

Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice

21 January 2018

1 reference

AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model

21 January 2018

1 reference

Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure

21 January 2018

1 reference

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

21 January 2018

1 reference

Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure

21 January 2018

1 reference

Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis.

21 January 2018

1 reference

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

21 January 2018

1 reference

21 January 2018

1 reference

Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy

21 January 2018

1 reference

Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations

21 January 2018

1 reference

Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.

21 January 2018

1 reference

Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy

21 January 2018

1 reference

Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.

21 January 2018

1 reference

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins

21 January 2018

1 reference

Targets for therapy in sarcomeric cardiomyopathies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26842371%20AND%20SRC:MED&resulttype=core&format=json

release_rcddpa4dfvhjbg3chbxxqkqqoe

7 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rcddpa4dfvhjbg3chbxxqkqqoe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference